Zur Rose brings Sfr200m rights issue to fund German M&A
Zur Rose, the Swiss online pharmacy that went public last year, plans to raise Sfr200m via a rights issue to fund its takeover of the e-commerce operations of Medpex, a competitor in Germany.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: